美股A股
StockGist
Back
8-K2026-03-09· grok-4-1-fast-non-reasoning

ANTX · AN2 Therapeutics, Inc.

0001193125-26-099169

SEC filing

Summary

AN2 Therapeutics, Inc. entered into a Securities Purchase Agreement on March 8, 2026, involving the offer and sale of unregistered securities including Pre-Funded Warrants and underlying shares of Common Stock. Exhibits include the Form of Pre-Funded Warrant and the Securities Purchase Agreement.

Key takeaways